Objective: To evaluate the effectiveness of olanzapine versus aripiprazole in patients with
schizophrenia. Method: Patients aged 18 to 65 years with schizophrenia (diagnosed …

BACKGROUND: Few studies have directly compared the efficacy and tolerability of atypical
agents. METHODS: This multicenter, randomized, double-blind study compared the efficacy …

Objective To compare the long-term efficacy and safety of aripiprazole with olanzapine in
patients with either acute relapsing or chronic, stable schizophrenia. Materials and methods …

Objective: Major mental disorders are associated with an increased risk for obesity-related
cardiovascular mortality, leading to interest in risk-reduction approaches that target weight …

Olanzapine treatment has been associated with clinically meaningful weight increases,
hypertriglyceridemia, insulin resistance, and diabetes mellitus. There are few options for …

Objective. The aim of the study was to compare efficacy and tolerability of aripiprazole with
olanzapine in the short-term treatment of schizophrenia in an Indian population. Method …

We conducted a secondary analysis of a completed study of the differential efficacy and side
effects of aripiprazole versus haloperidol in early-stage schizophrenia (ESS), a …

This multisite study was conducted to compare the efficacy and tolerability of combination
treatment with clozapine plus aripiprazole versus combination treatment with clozapine plus …

Objective: Combining antipsychotics is common practice in the treatment of schizophrenia.
This study investigated aripiprazole adjunctive to risperidone or quetiapine for treating …

Background Effectiveness of a drug is a key concept dependent on efficacy, safety, and
tolerability. Time to discontinuation of treatment is also representative of effectiveness. We …